about
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycansRANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathwayConstitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphomaHeparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients.Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide.Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.[Interference of hemoglobin variants on glycated hemoglobin measurement using Architect ci8200 immunoassay (Abbott Diagnostics)].Catalase rs769214 SNP in elderly malnutrition and during renutrition: is glucagon to blame?Human catalase gene promoter haplotype and cardiometabolic improvement after bariatric surgery
P50
Q28567974-D33F3F16-A687-46E3-B746-D417A16C0C14Q30592498-D01E68AA-41FB-4CE5-9F00-5FDC74D71247Q34255098-01C5CD54-67D5-4E82-8B4B-28D953EA2B7FQ36329663-FE47B683-A212-40E9-BBD2-B7627672986AQ37370632-042FA2C0-7A27-41FF-B3BE-6B41EA0DE8AEQ37513021-C7683552-6EAA-41FC-B9B5-2C093FD7B338Q38304234-9563AB7B-C10E-4710-827B-BEF164E62273Q38353710-AF4D20D1-EDBF-424C-9FA7-A46CA32CB370Q43280918-28B1E774-A3AB-46E4-BED0-4AD5DA2712B2Q43611915-CC52FBB2-057D-4CD3-9153-B6D3C09670E0Q47411438-64772FF7-116D-43AB-B5C7-DCED14CDFB36Q50682210-0538831F-1AB0-4051-859D-5221706BAF64Q50895861-9E07E4BC-674C-40FA-A618-EE734E74CEBEQ52399601-A8853BD3-0551-45C0-8873-6409296CF83CQ84729331-213561ED-4B35-419A-8F37-947057B5A8B7Q87928301-187699CE-5AD1-42B8-B403-FDA5AFEAD3D2
P50
description
Frans onderzoekster
@nl
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Christelle Laguillier-Morizot
@ast
Christelle Laguillier-Morizot
@de
Christelle Laguillier-Morizot
@en
Christelle Laguillier-Morizot
@es
Christelle Laguillier-Morizot
@fr
Christelle Laguillier-Morizot
@nl
Christelle Laguillier-Morizot
@pt
Christelle Laguillier-Morizot
@sl
Christelle Laguillier-Morizot
@sv
type
label
Christelle Laguillier-Morizot
@ast
Christelle Laguillier-Morizot
@de
Christelle Laguillier-Morizot
@en
Christelle Laguillier-Morizot
@es
Christelle Laguillier-Morizot
@fr
Christelle Laguillier-Morizot
@nl
Christelle Laguillier-Morizot
@pt
Christelle Laguillier-Morizot
@sl
Christelle Laguillier-Morizot
@sv
altLabel
Christelle Laguillier
@en
Christelle Laguillier
@fr
prefLabel
Christelle Laguillier-Morizot
@ast
Christelle Laguillier-Morizot
@de
Christelle Laguillier-Morizot
@en
Christelle Laguillier-Morizot
@es
Christelle Laguillier-Morizot
@fr
Christelle Laguillier-Morizot
@nl
Christelle Laguillier-Morizot
@pt
Christelle Laguillier-Morizot
@sl
Christelle Laguillier-Morizot
@sv
P214
P269
P106
P1412
P21
P213
0000 0003 5698 6772
P214
P269
P27
P31
P496
0000-0002-2704-9774
P569
1979-01-01T00:00:00Z
P7859
viaf-193979711